Eli Lilly, Taikang and Tencent are in line to exit the diabetes equipment maker, which has filed to go public in Hong Kong next week.

MicroTech Medical, a China-based medical device manufacturer backed by pharmaceutical firm Eli Lilly, insurer Taikang and internet group Tencent, has filed to list on the Hong Kong Stock Exchange.

The initial public offering is set to take place on October 19 and will involve the company issuing up to 63.5 million shares priced between HK$27.70 and HK$31.15 ($3.56-$4.00) each, which would enable it to raise up to $254m.

Founded in 2011, MicroTech is developing electronic equipment designed for use in…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Edison Fu

Edison Fu is a reporter and Asia liaison at Global Corporate Venturing.
Email LinkedIn